Cases by country, the UK and NHS pathway and other country lenses, the expert centres with trials on record, and the centres named on this cancer's subtypes.
No country-level case numbers. This cancer is not mapped to a GLOBOCAN site.
Baltimore · cancer center | United States | 0 | 2,962 | 42,161 | #10 | ||
Lausanne · hospital | Switzerland | none recorded | 0 | 838 | 14,951 | - | |
Brussels · cancer center | Belgium | none recorded | 0 | 489 | 8,689 | - | |
Madison, WI · cancer center | United States | 0 | 424 | 10,177 | - | ||
Birmingham · hospital | United Kingdom | none recorded | 0 | 220 | 1,999 | - | |
Indianapolis, IN · cancer center | United States | 0 | 159 | 4,238 | - | ||
Kampala · cancer center | Uganda | none recorded | 0 | 102 | 1,239 | - | |
Butaro · cancer center | Rwanda | none recorded | 0 | 5 | 9 | - | |
Varanasi · cancer center | India | none recorded | 0 | 0 | 0 | - |
These are the things we can measure; they are not a ranking of quality. Each column is a field on the institution record or a count over what OnCo has linked; a centre that treats many patients with Low-risk gestational trophoblastic neoplasia but is thinly recorded here will look small.
Not known: OnCo holds no case-volume or outcome figures for centres, so none are shown. Where a national audit or registry publishes them, the centre's page links to it. Default order: Newsweek rank, then trials for this cancer, then research output.